Yantai Dongcheng Pharmaceutical Co Ltd (002675) — Financial Flexibility Index
Yantai Dongcheng Pharmaceutical Co Ltd (002675) has a Financial Flexibility Index of 0.11x as of December 2025. Free cash flow of CN¥398.23 Million (operating CF CN¥239.54 Million minus capex CN¥158.69 Million) represents 0% of total liabilities (CN¥3.61 Billion). Check Yantai Dongcheng Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Yantai Dongcheng Pharmaceutical Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Yantai Dongcheng Pharmaceutical Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see 002675 cash flow conversion.
Annual Financial Flexibility Index for Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Yantai Dongcheng Pharmaceutical Co Ltd. Explore Yantai Dongcheng Pharmaceutical Co Ltd (002675) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | CN¥945.43 Million | CN¥584.61 Million | CN¥3.61 Billion | ▲ +15.1% |
| 2024 | 0.23x | CN¥743.25 Million | CN¥287.15 Million | CN¥3.26 Billion | ▼ -22.4% |
| 2023 | 0.29x | CN¥788.89 Million | CN¥276.94 Million | CN¥2.69 Billion | ▼ -38.7% |
| 2022 | 0.48x | CN¥1.39 Billion | CN¥996.54 Million | CN¥2.89 Billion | ▼ -14.5% |
| 2021 | 0.56x | CN¥1.47 Billion | CN¥943.58 Million | CN¥2.63 Billion | ▲ +62.8% |
| 2020 | 0.34x | CN¥834.76 Million | CN¥572.58 Million | CN¥2.43 Billion | ▼ -8.6% |
| 2019 | 0.38x | CN¥946.45 Million | CN¥696.38 Million | CN¥2.52 Billion | ▲ +44.4% |
| 2018 | 0.26x | CN¥614.12 Million | CN¥493.06 Million | CN¥2.36 Billion | ▲ +46.5% |
| 2017 | 0.18x | CN¥352.86 Million | CN¥208.94 Million | CN¥1.98 Billion | ▼ -35.7% |
| 2016 | 0.28x | CN¥327.45 Million | CN¥196.28 Million | CN¥1.18 Billion | ▼ -42.0% |
| 2015 | 0.48x | CN¥148.73 Million | CN¥66.69 Million | CN¥311.94 Million | ▼ -15.9% |
| 2014 | 0.57x | CN¥118.50 Million | CN¥52.00 Million | CN¥209.06 Million | ▼ -52.7% |
| 2013 | 1.20x | CN¥152.53 Million | CN¥-20.60 Million | CN¥127.18 Million | ▼ -25.0% |
| 2012 | 1.60x | CN¥116.50 Million | CN¥44.53 Million | CN¥72.84 Million | ▲ +50.0% |
| 2011 | 1.07x | CN¥156.55 Million | CN¥138.83 Million | CN¥146.82 Million | ▲ +145.3% |
| 2010 | 0.43x | CN¥73.07 Million | CN¥57.02 Million | CN¥168.14 Million | ▲ +1913.7% |
| 2009 | -0.02x | CN¥-3.03 Million | CN¥-26.60 Million | CN¥126.53 Million | ▼ -105.9% |
| 2008 | 0.40x | CN¥46.87 Million | CN¥41.57 Million | CN¥115.74 Million | — |